前言：目的：研究钙拮抗剂尼莫地平与乌红天麻种麻的协同镇痛作用。
Objective: To study the synergism analgesic action of ges and nimodipine, a calcium antagonist.
结论：PDGF在OIR组织中表达明显增加，而钙通道拮抗剂尼莫地平可抑制OIR的发生，并在某种程度上抑制PDGF的表达。
Conclusion: PDGF expression is obviously increased in OIR patients nimodipine can prevent OIR and it can inhibit the expression of PDGF to a certain extent.
方法：用荧光倒置显微镜来测定癫痫状态下海马CA1、CA3区钙超载的情况，并用钙离子拮抗剂尼莫地平作用于海马脑片看钙超载的变化。
Methods: calcium overloading in hippocampal CA1, CA3 region of epileptic rats was measured using a fluorescent inverted microscope, and the inhibition by the nimodipine was observed, too.
采用透皮扩散装置和兔皮，进行了尼莫地平透皮促进剂的研究。
The in vitro Penetration enhancers for nimodipine was studied using diffusion equipment and rabbit skin.
结论：尼莫地平分子微囊剂的生物利用度高于尼莫通片。
Conclusion: The bioavailability of nimodipine molecular microcapsule is higher than that of nimodipine tablet.
目的建立简便的紫外分光光度法测定尼莫地平体外经皮渗透量，并考察不同促渗剂对尼莫地平的体外经皮渗透影响。
OBJECTIVE To establish a simple method of UV spectrophotometry for the permeative determination of nimodipine, and to search suitable enhancers for the permeability of nimodipine.
钙离子拮抗剂—尼莫地平有重要的脑保护作用。
Nimodipine, a calcium-channel antagonist has importment brain protection role.
方法 考察了尼莫地平在不同的油及乳化剂中的平衡溶解度；
METHODS The equilibrium solubility of nimodipine in different compositions of oils and emulsifiers was investigated.
在服尼莫地平治疗期间停服其他钙离子拮抗剂及其他对治疗产生影响的药物。
During nimodipine treatment in the service stop taking other calcium antagonists and other drugs that affect treatment.
目的建立简便的紫外分光光度法测定尼莫地平体外经皮渗透量，并考察不同促渗剂对尼莫地平的体外经皮渗透影响。
Objective: To investigate penetration characteristics of artemether and the effect of different permeation enhancer on transdermal permeation of artemether through rat skin.
目的建立简便的紫外分光光度法测定尼莫地平体外经皮渗透量，并考察不同促渗剂对尼莫地平的体外经皮渗透影响。
Objective: To investigate penetration characteristics of artemether and the effect of different permeation enhancer on transdermal permeation of artemether through rat skin.
应用推荐